Skip to main content

Table 3 Variables related with SVR at univariate and multivariate analysis (PP).

From: Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV

  Univariate analysis Multivariate analysis
Variables OR
(IC 95%)
pvalue OR
(IC 95%)
pvalue
HCV-RNA >500.000 IU/ml 0.4 (0.2-0.7) 0.0019 0.41 (0.23 - 0.75) 0.004
PegIFN alfa-2b vs alfa-2a 0.58 (0.3-1.15) 0.098 0.48 (0.24-0.97) 0.041
Stop RBV 0.25 (0.1-0.5) 0.0001 0.24 (0.1-0.5) 0.0004
PLT <130.000 cell/mm3 0.5 (0.2-1.3) 0.1575 0.83 (0.3-2.2) 0.715
Cirrhosis 0.6 (0.3-1.7) 0.3616   
Age >45 years 0.7 (0.4-1.2) 0.1868 0.73 (0.4-1.34) 0.31
HIV infection 1.1 (0.5-2.6) 0.8159 1.87 (0.49-7.12) 0.36
RBV reduction 1.7 (0.7-4.6) 0.2287   
PegIFN reduction 0.9 (0.4-2.2) 0.8685   
Gender (male vs female) 0.7 (0.3-1.2) 0.1868 0.67 (0.3-1.3) 0.24
HCV genotype 2 vs 3 1 (0.6-1.8) 0.9   
Variables SVR no SVR
yes
p value OR
(IC 95%)
p value
Weeks of treatment, mean (SD) 27 (14) 25
(12)
0.18 0.98 (0.947-1) 0.39